164 related articles for article (PubMed ID: 7043498)
21. Pimozide in chronic schizophrenic outpatients.
Clark ML; Huber WK; Hill D; Wood F; Costiloe JP
Dis Nerv Syst; 1975 Mar; 36(3):137-41. PubMed ID: 1112170
[TBL] [Abstract][Full Text] [Related]
22. Haloperidol and lorazepam combined: clinical effects and drug plasma levels in the treatment of acute schizophrenic psychosis.
Stevens A; Stevens I; Mahal A; Gaertner HJ
Pharmacopsychiatry; 1992 Nov; 25(6):273-7. PubMed ID: 1494594
[TBL] [Abstract][Full Text] [Related]
23. [Disagreement in standardized haloperidol treatment in comparison with "adequate individual dosage" of acutely schizophrenic patients].
Klieser E; Lehmann E
Fortschr Neurol Psychiatr; 1992 Mar; 60(3):126-9. PubMed ID: 1577361
[TBL] [Abstract][Full Text] [Related]
24. Haloperidol plasma level after a test dose as predictor for the clinical response to treatment in acute schizophrenic patients.
Louza Neto MR; Müller-Spahn F; Rüther E; Scherer J
Pharmacopsychiatry; 1988 Sep; 21(5):226-31. PubMed ID: 3227054
[TBL] [Abstract][Full Text] [Related]
25. The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol.
Silverstone T; Cookson J; Ball R; Chin CN; Jacobs D; Lader S; Gould S
J Psychiatr Res; 1984; 18(3):255-68. PubMed ID: 6387105
[TBL] [Abstract][Full Text] [Related]
26. Initial improvement as a criterion for drug choice in acute schizophrenia.
Klimke A; Klieser E; Lehmann E; Miele L
Pharmacopsychiatry; 1993 Jan; 26(1):25-9. PubMed ID: 8104348
[TBL] [Abstract][Full Text] [Related]
27. A double-blind controlled trial of pipotiazine, haloperidol and placebo in recently-hospitalized acute schizophrenic patients.
Bechelli LP; Ruffino-Netto A; Hetem G
Braz J Med Biol Res; 1983 Dec; 16(4):305-11. PubMed ID: 6143579
[TBL] [Abstract][Full Text] [Related]
28. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.
Sallee FR; Nesbitt L; Jackson C; Sine L; Sethuraman G
Am J Psychiatry; 1997 Aug; 154(8):1057-62. PubMed ID: 9247389
[TBL] [Abstract][Full Text] [Related]
29. Comparison of pimozide and chlorpromazine in acute schizophrenia.
Pecknold JC; McClure DJ; Allan T; Wrzesinski L
Can J Psychiatry; 1982 Apr; 27(3):208-12. PubMed ID: 7046898
[TBL] [Abstract][Full Text] [Related]
30. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.
Shapiro E; Shapiro AK; Fulop G; Hubbard M; Mandeli J; Nordlie J; Phillips RA
Arch Gen Psychiatry; 1989 Aug; 46(8):722-30. PubMed ID: 2665687
[TBL] [Abstract][Full Text] [Related]
31. Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
McCreadie RG; Dingwall JM; Wiles DH; Heykants JJ
Br J Psychiatry; 1980 Dec; 137():510-7. PubMed ID: 7011468
[TBL] [Abstract][Full Text] [Related]
32. Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations.
Gerlach J; Behnke K; Heltberg J; Munk-Anderson E; Nielsen H
Br J Psychiatry; 1985 Sep; 147():283-8. PubMed ID: 3904885
[TBL] [Abstract][Full Text] [Related]
33. Pimozide in the treatment of newly admitted schizophrenic patients.
Chouinard G; Annable L
Psychopharmacology (Berl); 1982; 76(1):13-9. PubMed ID: 6805002
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Gilles de la Tourette syndrome with pimozide.
Shapiro AK; Shapiro E; Eisenkraft GJ
Am J Psychiatry; 1983 Sep; 140(9):1183-6. PubMed ID: 6351642
[TBL] [Abstract][Full Text] [Related]
35. Pimozide in acute schizophrenia: a pilot study.
Garton D; Silverstone T
Curr Med Res Opin; 1979; 5(10):799-806. PubMed ID: 373996
[TBL] [Abstract][Full Text] [Related]
36. Positive versus negative symptoms in schizophrenia: response to haloperidol.
Palao DJ; Arauxo A; Brunet M; Marquez M; Bernardo M; Ferrer J; Gonzalez-Monclus E
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):155-64. PubMed ID: 8115670
[TBL] [Abstract][Full Text] [Related]
37. Sulpiride versus haloperidol, a clinical trial in schizophrenia. A preliminary report.
Munk-Andersen E; Behnke K; Heltberg J; Nielsen H; Gerlach J
Acta Psychiatr Scand Suppl; 1984; 311():31-41. PubMed ID: 6367362
[TBL] [Abstract][Full Text] [Related]
38. Experimental comparison of the effectivity of individually adapted and standardized dosages of haloperidol.
Klieser E; Lehmann E
Neuropsychobiology; 1987; 18(3):122-6. PubMed ID: 3453428
[TBL] [Abstract][Full Text] [Related]
39. Acute high-dose parenteral haloperidol treatment of psychosis.
Lerner Y; Lwow E; Levitin A; Belmaker RH
Am J Psychiatry; 1979 Aug; 136(8):1061-4. PubMed ID: 380367
[TBL] [Abstract][Full Text] [Related]
40. Suspension therapy in acute schizophrenia. Clinical and neuroendocrine/biochemical effects of abrupt discontinuation of neuroleptic medication.
Kuhs H; Folkerts H
Neuropsychobiology; 1995; 31(3):135-45. PubMed ID: 7609862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
